Biostax Corp. (BTAX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Sep 25, 2026
Biostax Market Cap
Biostax has a market cap or net worth of $21.65 thousand as of October 20, 2026. It is the 51,564th most valuable company in the world and the 7,599th biggest in the United States. Its market cap has increased by 150.78% in one year.
Market Cap
21.65K
Enterprise Value
1.18M
Revenue
n/a
Global Rank
Country Rank
#7,599 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 14, 2012, Biostax's market cap has decreased from 377.40K to 21.65K, a decrease of -94.26%. That is a compound annual growth rate of -18.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 21.65K | -98.38% |
| Dec 31, 2024 | 1.34M | -78.10% |
| Dec 28, 2023 | 6.11M | -87.74% |
| Dec 30, 2022 | 49.83M | 3,358.09% |
| Dec 30, 2021 | 1.44M | -78.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Itoco | 42.82K |
| Nascent Biotech | 34.57K |
| Burzynski Research Institute | 26.29K |
| Carisma Therapeutics | 20.92K |
| Health Sciences Group | 20.51K |
| Scopus BioPharma | 16.83K |
| Anebulo Pharmaceuticals | 16.31K |
| Bio-Path Holdings | 16.17K |